But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who benefited said the improvement didn’t last.
Category: Long Covid
-
Covid Normalcy: No Tests, Isolation or Masks
For many, Covid is increasingly regarded like the common cold. A scratchy throat and canceled plans bring a bewildering new critique from friends: You shouldn’t have tested.
-
A Virtuoso Cellist’s Painstaking Path From Long Covid Back to the Stage
For over three years, long Covid has presented Joshua Roman with health challenges — and has indelibly shaped the music he makes.
-
About 400 Million People Worldwide Have Had Long Covid, Researchers Say
The condition has put significant strain on patients and society — at a global economic cost of about $1 trillion a year, a new report estimates.
-
Runner With Long Covid Creates Flagstaff’s Dream Run Camp
With long Covid ending his own days as an endurance athlete, Matt Fitzgerald opened the doors of his home, creating a fantasy camp for runners with a dream.
-
Long Covid Is Keeping Significant Numbers of People Out of Work, Study Finds
The New York Times – Business:An analysis of workers’ compensation claims in New York found that 71 percent of claimants with long Covid needed continuing medical treatment or were unable to work for six months or more.
-
Britain’s Economic Health Is Withering With Sick Workers on the Sidelines
The New York Times – Business:Many people who want to work can’t because of long-term health problems, a persistent issue that is causing Britain’s economy to go “into reverse.”
-
Paxlovid May Reduce Risk of Long Covid in Eligible Patients, Study Finds
The New York Times – Business:The research looked at patients who qualified for the antiviral through age or health conditions. Those who took it shortly after infection were 26 percent less likely to have symptoms 90 days later.
